Journal of Tokyo Women's Medical University
Online ISSN : 2432-6178
Print ISSN : 0040-9022
ISSN-L : 0040-9022
COVID-19 Pandemic
Drug Development and Drug Treatment
Fujiko TsukaharaYoshiro Maru
Author information
JOURNAL OPEN ACCESS

2021 Volume 91 Issue 1 Pages 19-28

Details
Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019. It has been rapidly spreading worldwide ever since. The majority of COVID-19 infections are asymptomatic or mildly symptomatic. However, old age or comorbidities can result in a cytokine storm, which eventually leads to death. To date, no drug has been clinically proven effective to treat COVID-19, and development of effective drugs against SARS-CoV-2 is urgently required. Several drugs used in treating other diseases are being evaluated. Clinical trials on many new antiviral drugs and vaccine candidates are also rapidly ongoing. In this review, we summarized the currently used drugs and newly developed vaccines for the treatment of COVID-19.

Content from these authors
© 2021 Society of Tokyo Women's Medical University

この記事はクリエイティブ・コモンズ [表示 4.0 国際]ライセンスの下に提供されています。 This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/deed.ja
Previous article Next article
feedback
Top